CMS releases data on drug spending

• Main Author: Robbins RA
• Format: Article
• Language: English
• Published: Arizona Thoracic Society 2016-11-01
• Series: Southwest Journal of Pulmonary and Critical Care
• Subjects: CMS; Medicare; Medicaid; drug; spending; price; respiratory; generic; rebates; expenditures
• Online Access: http://www.swjpcc.com/news/2016/11/15/cms-releases-data-on-drug-spending.html

No abstract available. Article truncated at 150 words. Yesterday (11/14/16) the Centers for Medicare and Medicaid Services (CMS) released data on spending for drugs under Medicare and Medicaid (1,2). Medicare paid $137.4 billion on drugs covered by its prescription drug benefit in 2015. About $8.7 billion of that spending occurred on drugs that had "large" price hikes, defined as a more than 25 percent increase between 2014 and 2015. In 2015, Medicaid paid $57.3 billion about $5.1 billion of which was spent on drugs that had large price increases. The Medicare spending database highlights 11 drugs that doubled in price. The Medicaid database identified 20 drugs that more than doubled in price with 9 of these being old, generic drugs. Medicare drugs were led by Glumetza, a Type 2 diabetes drug which saw its price soar 380 percent and hydroxychloroquine sulfate, a generic malaria drug, which went up 370 percent. Medicaid drugs were led by Ativan, an anti-anxiety ...